EUROFINS SCIENTIFIC (ESF0.DE) Stock Fundamental Analysis
FRA:ESF0 - FR0014000MR3 - Common Stock
63.6 EUR
0 (0%)
Taking everything into account, ESF0 scores 6 out of 10 in our fundamental rating. ESF0 was compared to 18 industry peers in the Life Sciences Tools & Services industry. While ESF0 has a great profitability rating, there are some minor concerns on its financial health. ESF0 scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
ESF0 had positive earnings in the past year.
In the past year ESF0 had a positive cash flow from operations.
In the past 5 years ESF0 has always been profitable.
In the past 5 years ESF0 always reported a positive cash flow from operatings.
1.2 Ratios
ESF0 has a Return On Assets of 3.54%. This is comparable to the rest of the industry: ESF0 outperforms 50.00% of its industry peers.
Looking at the Return On Equity, with a value of 8.09%, ESF0 is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
The Return On Invested Capital of ESF0 (9.79%) is better than 83.33% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ESF0 is in line with the industry average of 7.14%.
The last Return On Invested Capital (9.79%) for ESF0 is above the 3 year average (8.70%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROIC | 9.79% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
1.3 Margins
ESF0 has a worse Profit Margin (5.44%) than 61.11% of its industry peers.
ESF0's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 15.59%, ESF0 is in the better half of the industry, outperforming 61.11% of the companies in the same industry.
ESF0's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 23.29%, ESF0 is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of ESF0 has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% |
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ESF0 is still creating some value.
Compared to 1 year ago, ESF0 has less shares outstanding
Compared to 5 years ago, ESF0 has more shares outstanding
ESF0 has a better debt/assets ratio than last year.
2.2 Solvency
ESF0 has an Altman-Z score of 2.73. This is not the best score and indicates that ESF0 is in the grey zone with still only limited risk for bankruptcy at the moment.
ESF0's Altman-Z score of 2.73 is in line compared to the rest of the industry. ESF0 outperforms 50.00% of its industry peers.
The Debt to FCF ratio of ESF0 is 5.25, which is a neutral value as it means it would take ESF0, 5.25 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ESF0 (5.25) is better than 61.11% of its industry peers.
ESF0 has a Debt/Equity ratio of 0.77. This is a neutral value indicating ESF0 is somewhat dependend on debt financing.
ESF0's Debt to Equity ratio of 0.77 is on the low side compared to the rest of the industry. ESF0 is outperformed by 72.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Altman-Z | 2.73 |
ROIC/WACC1.33
WACC7.37%
2.3 Liquidity
ESF0 has a Current Ratio of 1.26. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.26, ESF0 is doing worse than 83.33% of the companies in the same industry.
ESF0 has a Quick Ratio of 1.19. This is a normal value and indicates that ESF0 is financially healthy and should not expect problems in meeting its short term obligations.
ESF0's Quick ratio of 1.19 is in line compared to the rest of the industry. ESF0 outperforms 55.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 16.50% over the past year.
The Earnings Per Share has been growing by 18.34% on average over the past years. This is quite good.
Looking at the last year, ESF0 shows a small growth in Revenue. The Revenue has grown by 2.53% in the last year.
The Revenue has been growing by 8.78% on average over the past years. This is quite good.
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
3.2 Future
The Earnings Per Share is expected to grow by 12.69% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.22% on average over the next years.
EPS Next Y13.37%
EPS Next 2Y13.55%
EPS Next 3Y13.96%
EPS Next 5Y12.69%
Revenue Next Year5.88%
Revenue Next 2Y6.06%
Revenue Next 3Y6.35%
Revenue Next 5Y6.22%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
ESF0 is valuated rather expensively with a Price/Earnings ratio of 17.67.
Compared to the rest of the industry, the Price/Earnings ratio of ESF0 indicates a rather cheap valuation: ESF0 is cheaper than 83.33% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.03, ESF0 is valued a bit cheaper.
The Price/Forward Earnings ratio is 15.97, which indicates a correct valuation of ESF0.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ESF0 indicates a rather cheap valuation: ESF0 is cheaper than 83.33% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.54. ESF0 is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.67 | ||
| Fwd PE | 15.97 |
4.2 Price Multiples
ESF0's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ESF0 is cheaper than 83.33% of the companies in the same industry.
83.33% of the companies in the same industry are more expensive than ESF0, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 14.78 | ||
| EV/EBITDA | 8.79 |
4.3 Compensation for Growth
ESF0's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of ESF0 may justify a higher PE ratio.
ESF0's earnings are expected to grow with 13.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.32
PEG (5Y)0.96
EPS Next 2Y13.55%
EPS Next 3Y13.96%
5. Dividend
5.1 Amount
With a yearly dividend of 0.96%, ESF0 is not a good candidate for dividend investing.
ESF0's Dividend Yield is rather good when compared to the industry average which is at 0.73. ESF0 pays more dividend than 88.89% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, ESF0's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.96% |
5.2 History
On average, the dividend of ESF0 grows each year by 16.51%, which is quite nice.
Dividend Growth(5Y)16.51%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
54.91% of the earnings are spent on dividend by ESF0. This is a bit on the high side, but may be sustainable.
ESF0's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP54.91%
EPS Next 2Y13.55%
EPS Next 3Y13.96%
FRA:ESF0 (9/10/2025, 7:00:00 PM)
63.6
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners34.16%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap11.59B
Analysts70
Price Target64.58 (1.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.96% |
Yearly Dividend0.52
Dividend Growth(5Y)16.51%
DP54.91%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.71%
PT rev (3m)10.33%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.66%
EPS NY rev (3m)-1.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.67 | ||
| Fwd PE | 15.97 | ||
| P/S | 1.68 | ||
| P/FCF | 14.78 | ||
| P/OCF | 8.81 | ||
| P/B | 2.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.79 |
EPS(TTM)3.6
EY5.66%
EPS(NY)3.98
Fwd EY6.26%
FCF(TTM)4.3
FCFY6.77%
OCF(TTM)7.22
OCFY11.35%
SpS37.84
BVpS25.45
TBVpS-3.69
PEG (NY)1.32
PEG (5Y)0.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.09% | ||
| ROCE | 12.64% | ||
| ROIC | 9.79% | ||
| ROICexc | 10.74% | ||
| ROICexgc | 34.1% | ||
| OM | 15.59% | ||
| PM (TTM) | 5.44% | ||
| GM | 23.29% | ||
| FCFM | 11.37% |
ROA(3y)3.79%
ROA(5y)5.05%
ROE(3y)7.94%
ROE(5y)10.72%
ROIC(3y)8.7%
ROIC(5y)10.54%
ROICexc(3y)9.52%
ROICexc(5y)11.6%
ROICexgc(3y)31.02%
ROICexgc(5y)39.55%
ROCE(3y)11.31%
ROCE(5y)13.7%
ROICexcg growth 3Y-18.17%
ROICexcg growth 5Y3.78%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y6.63%
OM growth 3Y-11.93%
OM growth 5Y3.56%
PM growth 3Y-23.05%
PM growth 5Y9.75%
GM growth 3Y-7.6%
GM growth 5Y1.83%
F-Score7
Asset Turnover0.65
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | 5.25 | ||
| Debt/EBITDA | 2.1 | ||
| Cap/Depr | 84.94% | ||
| Cap/Sales | 7.7% | ||
| Interest Coverage | 9.93 | ||
| Cash Conversion | 77.37% | ||
| Profit Quality | 209.21% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.73 |
F-Score7
WACC7.37%
ROIC/WACC1.33
Cap/Depr(3y)89.21%
Cap/Depr(5y)85.64%
Cap/Sales(3y)8.63%
Cap/Sales(5y)7.99%
Profit Quality(3y)162.79%
Profit Quality(5y)158.88%
High Growth Momentum
Growth
EPS 1Y (TTM)16.5%
EPS 3Y-21.42%
EPS 5Y18.34%
EPS Q2Q%19.61%
EPS Next Y13.37%
EPS Next 2Y13.55%
EPS Next 3Y13.96%
EPS Next 5Y12.69%
Revenue 1Y (TTM)2.53%
Revenue growth 3Y1.14%
Revenue growth 5Y8.78%
Sales Q2Q%5.64%
Revenue Next Year5.88%
Revenue Next 2Y6.06%
Revenue Next 3Y6.35%
Revenue Next 5Y6.22%
EBIT growth 1Y14.03%
EBIT growth 3Y-10.93%
EBIT growth 5Y12.66%
EBIT Next Year87.7%
EBIT Next 3Y30.85%
EBIT Next 5Y22.29%
FCF growth 1Y113.13%
FCF growth 3Y-7.69%
FCF growth 5Y25.62%
OCF growth 1Y31.31%
OCF growth 3Y-4.44%
OCF growth 5Y14.24%